Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs (French, HTML)

Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs: French HTML file. From Health Canada, updated Jun 2022. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2022-06-07

This guidance document applies to all biologic drug submissions where the sponsor seeks authorization for sale based on demonstrated similarity to a previously approved biologic drug and relies, in part, on prior information regarding that biologic drug in order to present a reduced clinical and non-clinical package as part of the submission.

Access original file

Data overview

Formats
HTML
File languages
French
Available actions
Access original file

Official sources and licences

Related open data